G Tech Bio

G Tech Bio is a private California biotechnology company associated with early-stage gene and cell therapy work. Public disclosures indicate it provided consulting and licensing support for programs in HIV and hepatitis B and worked on a genetically enhanced dendritic cell platform intended for broad application in cancer and infectious diseases. The company appears to have operated primarily as a small private entity rather than a fully built-out clinical-stage drug developer. Available public information is sparse, and no independently verified clinical pipeline, commercial product portfolio, or active corporate website was identified. Based on the available record, G Tech Bio is best characterized as an early-stage private biotech focused on gene therapy, cell therapy, and immunotherapy-related platform concepts.